We work to improve the clinical care and access to research for people with Parkinson’s, atypical parkinsonian and movement disorders. Our research has won us numerous awards and recognition in the international community.
We are a unique grouping of clinicians, basic scientists and translational researchers working towards improved earlier diagnosis and treatments for people with Parkinson’s (PD) and other movement disorders.
Based at the John Radcliffe Hospital, Oxford our NHS service includes clinics for Medical Parkinson’s and Movement Disorders; Atypical Parkinsonian Disorders including MSA, PSP and CBD; Surgical Movement Disorders; PD elderly care; and Botulinum toxin for dystonia.
Our translational research programme integrates with our clinical service and focuses on developing a cure for Parkinson’s (OPDC), mechanisms of electrical dysfunction within brain cells, and Deep Brain Stimulation/surgical therapies for PD and movement disorders.
Research Projects & Links
Supports the Monument Discovery project.
A Phase 2 RCT of intracerebroventricular administration of platelet-derived growth factor (pdGF) in PD. One of 5 European centres involved in the EU funded FP7 project. The Principal Investigators are Mr Alex Green and Dr Marko Bogdanovich.
NB Referring clinicians please see the hospital website for information about referrals.
The following clinics are available through choose and book or direct written consultant referral:
- Medical Parkinson’s and Movement Disorders clinic (JR: Dr’s Michele Hu, Bin Cheeran, George Tofaris, Professor Peter Brown, Nurse specialist Angie Weir; Horton General Hospital: Professor Peter Brown, Jackie Palace)
- Atypical Parkinsons clinic (MSA and PSP- Dr Michele Hu, John Radcliffe Hospital)
- PD Geratology Clinic (Dr Sudhir Singh- John Radcliffe Hospital)
- Surgical Parkinson’s and Movement Disorders clinic (Dr Marko Bogdanovic, Professor Tipu Aziz, Mr Alex Green, Mr James Fitzgerald- John Radcliffe Hospital)
- Botulinum toxin in dystonia clinic: (Dr Sunil Wimalaratna- John Radcliffe Hospital)
RAFT Thames Valley Patient Database for individuals interested in future research participation with Parkinson’s and atypical parkinsonism: for more details please email.
NIHR DeNDRoN provides a research infrastructure within the NHS. It supports the delivery of clinical research in ataxia, dementias, Huntington’s disease, motor neurone disease and Parkinson’s disease across Berkshire, Buckinghamshire, Milton Keynes, Northamptonshire, Leicestershire and Oxfordshire. It is managed against an agreed set of performance measures including patient recruitment targets.